Efficacy of early rituximab treatment in primary Sjögren’s syndrome: a systematic review and meta-analysis
Objective: This systematic review and meta-analysis aimed to assess Rituximab (RTX)’s efficacy and safety in primary Sjögren’s syndrome (pSS), particularly how treatment timing influences outcomes.Methods : : The study included randomized controlled trials (RCTs) and quasi-experimental studies evalu...
Saved in:
| Main Authors: | Mohammad Shahdadian, Mohammad Ali Saghiri, Eugenio Capitle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean College of Rheumatology
2025-07-01
|
| Series: | Journal of Rheumatic Diseases |
| Subjects: | |
| Online Access: | http://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2024.0149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome
by: Xiao Zheng, et al.
Published: (2025-06-01) -
USE OF RITUXIMAB IN PATIENTS WITH SYSTEMIC MANIFESTATIONS OF PRIMARY SJOGREN'S SYNDROME
by: O. A. Logvinenko, et al.
Published: (2014-12-01) -
Rituximab in the treatment of nodal Bcell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis
by: O A Logvinenko, et al.
Published: (2008-10-01) -
Efficacy and safety of low dose rituximab in pemphigus: an updated systematic review and meta-analysis
by: Si-Han Liu, et al.
Published: (2025-07-01) -
Evaluation of effectiveness of long-term therapy with Russian rituximab biosimilar in Sjogren’s disease in real clinical practice
by: B. D. Chaltsev, et al.
Published: (2025-07-01)